Munafa Stock Market Course + Intraday & FNO calls 
Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Halozyme Therapeutics (HALO)
Technical Analysis Report for NASDAQ stock HALO Halozyme Therapeutics. Dated: 03 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock HALO Halozyme Therapeutics then click here. or read Experts views on Halozyme Therapeutics or Forecast & share price targets of Halozyme Therapeutics
Halozyme Therapeutics Opened at 68.47 and Closed at: 69.40, which is -0.65% of previous session's close. It moved within a range of 68.12 and 69.61
The session was a Bullish session with an average volume of 1787500, which is -15.41% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 6 days back on short term averages
A Dead cross was found 2 days back on mid term averages
Support for tomorrow is 68.76 and resistance for tomorrow is 70.25
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 68.48, 67.55 resistance for tomorrow's hourly charts is 69.97, 70.53
10 Day SMA for Halozyme Therapeutics (HALO) is 70.56 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Halozyme Therapeutics (HALO) is 74.98 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Halozyme Therapeutics (HALO) is 72.62 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 69.76 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Halozyme Therapeutics is 66.3 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Halozyme Therapeutics is at 74.98 and 200 DMA is at 66.3, while 50 DMA and 100 DMA are at 72.62 and 69.76 respectively
Halozyme Therapeutics (HALO) moving average of 20 SMA is at 74.98 and 20 EMA is at 72.61
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Tue Mar | 69.40 | 74.98 | 72.61 |
| 02 Mon Mar | 69.85 | 75.34 | 72.95 |
| 27 Fri Feb | 69.53 | 75.57 | 73.28 |
| 26 Thu Feb | 69.24 | 75.68 | 73.67 |
| 25 Wed Feb | 70.35 | 75.88 | 74.14 |
| 24 Tue Feb | 70.36 | 76.01 | 74.54 |
Halozyme Therapeutics (HALO) moving average of 50 SMA is at 72.62 and 50 EMA is at 72.3
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Tue Mar | 69.40 | 72.62 | 72.3 |
| 02 Mon Mar | 69.85 | 72.53 | 72.42 |
| 27 Fri Feb | 69.53 | 72.45 | 72.52 |
| 26 Thu Feb | 69.24 | 72.35 | 72.64 |
| 25 Wed Feb | 70.35 | 72.23 | 72.78 |
| 24 Tue Feb | 70.36 | 72.07 | 72.88 |
Halozyme Therapeutics (HALO) moving average of 100 SMA is at 69.76 and 100 EMA is at 70.6
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Tue Mar | 69.40 | 69.76 | 70.6 |
| 02 Mon Mar | 69.85 | 69.72 | 70.62 |
| 27 Fri Feb | 69.53 | 69.68 | 70.64 |
| 26 Thu Feb | 69.24 | 69.65 | 70.66 |
| 25 Wed Feb | 70.35 | 69.65 | 70.69 |
| 24 Tue Feb | 70.36 | 69.66 | 70.7 |
Halozyme Therapeutics (HALO) moving average of 200 SMA is at 66.3 and 200 EMA is at 67.48
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Tue Mar | 69.40 | 66.3 | 67.48 |
| 02 Mon Mar | 69.85 | 66.19 | 67.46 |
| 27 Fri Feb | 69.53 | 66.09 | 67.44 |
| 26 Thu Feb | 69.24 | 66.08 | 67.42 |
| 25 Wed Feb | 70.35 | 66.06 | 67.4 |
| 24 Tue Feb | 70.36 | 66.05 | 67.37 |
Vericel Corporation has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Vericel Corporation, about 4.2% more returns!
Urogen Pharma has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Urogen Pharma, about 1.82% more returns!
Halozyme Therapeutics has performed better than Theravance Biopharma in short term. Holding Halozyme Therapeutics could be a better choice for now!
Syndax Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 15.7% more returns!
Surgery Partners has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Surgery Partners, about 10.02% more returns!
Ultragenyx Pharmaceutical has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 0.34% more returns!
Halozyme Therapeutics has performed better than Uniqure N in short term. Holding Halozyme Therapeutics could be a better choice for now!
Prothena Corporation has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Prothena Corporation, about 16.24% more returns!
Insulet Corporation has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Insulet Corporation, about 7.21% more returns!
Novocure has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Novocure, about 26% more returns!
Livanova Plc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Livanova Plc, about 15.54% more returns!
Aldeyra Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 8.84% more returns!
Halozyme Therapeutics has performed better than Atricure Inc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Axsome Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Celldex Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 30.19% more returns!
Enanta Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 20.15% more returns!
Exact Sciences has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Exact Sciences, about 12.03% more returns!
Integra Lifesciences has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Integra Lifesciences, about 6.26% more returns!
Halozyme Therapeutics Technical analysis of indicators
Price action analysis of Halozyme Therapeutics (HALO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 71.27 and Halozyme Therapeutics HALO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics HALO stock. Volume based technical analysis of Halozyme Therapeutics HALO stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock HALO Halozyme Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And HALO Experts View which covers a lot of information including buying and selling signals
HALO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Halozyme Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
